Amatuximab Completed Phase 2 Trials for Malignant Pleural Mesothelioma (MPM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma